In this study we identified the involvement of reactive oxygen species (ROS) in signaling and biological effects of the angiopoietin-1 (Ang-1)/tie-2 receptor pathway. Exposure of human umbilical vein endothelial cells to Ang-1 (50 ng/ml) induced rapid and transient production of ROS, particularly superoxide anions. ROS production was attenuated by preincubation with a peptide (gp91ds-tat) that inhibits the association of the gp91 phox subunit with the p47 phox subunit of NADPH oxidase and by the expression of a dominant-negative form of Rac-1 (Rac1N17). These results suggest that ROS production in response to Ang-1 exposure originates mainly from a Rac-1-dependent NADPH oxidase. Overexpression of antioxidants (superoxide dismutase and catalase) and Rac1N17, as well as preincubation with selective inhibitors of NADPH oxidase augmented basal p38 phosphorylation, inhibited Ang-1-induced PAK-1 phosphorylation and potentiated Ang-1-induced Erk1/2 phosphorylation but had no influence on AKT and SAPK/JNK phosphorylation by Ang-1. Exposure to Ang-1 (100 ng/ml) for 5 h induced a threefold increase in endothelial cell migration, a response that was strongly inhibited by overexpression of antioxidants, Rac1N17, and selective NADPH oxidase inhibitors. We conclude that activation of tie-2 receptors by Ang-1 triggers the production of ROS through activation of NADPH oxidase and that ROS generation by Ang-1 promotes endothelial cell migration while negatively regulating Erk1/2 phosphorylation. ngiogenesis is a complex process responsible for the growth of new capillaries from preexisting vessels and is critical for embryonic vascular development and neovascularization in adult mammals, both under normal (ovaries in females) and pathological conditions, including tumor growth and metastasis, retinal vasculopathy, and arthritis (1). Endothelial cell (EC)-specific receptor tyrosine kinases (RTKs), including those of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) families, are critical for angiogenesis (1). Recently, angiopoietin-1 (Ang-1) and its receptor, tyrosine kinase with immunoglobulin and EGF-like domains (tie-2), also emerged as an important contributor to angiogenesis (2).
ngiogenesis is a complex process responsible for the growth of new capillaries from preexisting vessels and is critical for embryonic vascular development and neovascularization in adult mammals, both under normal (ovaries in females) and pathological conditions, including tumor growth and metastasis, retinal vasculopathy, and arthritis (1). Endothelial cell (EC)-specific receptor tyrosine kinases (RTKs), including those of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) families, are critical for angiogenesis (1). Recently, angiopoietin-1 (Ang-1) and its receptor, tyrosine kinase with immunoglobulin and EGF-like domains (tie-2), also emerged as an important contributor to angiogenesis (2).
Tie-2 receptors are RTKs that are selectively expressed in ECs and play an important role in embryonic vascular development, as indicated by embryonic lethality due to major vascular abnormalities when these receptors are genetically deleted in mice (3). Ang-1 has recently been identified as the main endogenous agonist for tie-2 receptors, and its genetic deletion produces similar phentotypic changes to those found in tie-2 −/− mice, including embryonic lethality, apoptosis, and immaturity of vascular cells (4, 5) . Recent studies have revealed that activation of tie-2 by Ang-1 in mature vasculature or cultured ECs elicits pro-angiogenic effects, including promotion of in vitro EC differentiation, tube formation, sprouting, migration, adherence, and survival (6) (7) (8) (9) . Injection or overexpression of Ang-1 in adult animals potentiates the angiogenic effects of VEGF in corneal neovascularization preparations, reduces vascular leakage, and attenuates many of the proinflammatory manifestations of tumor necrosis factor (TNF), including the expression of adhesion molecules and tissue factor (10, 11) .
Recent studies addressing the signaling mechanisms of tie-2 receptors have revealed that phosphatases and adaptor proteins, including Shp2, Grb14, Grb7, Grb2, and the p85 subunit of the phosphatidylinositol 3′-kinase (PI3-K), associate with tyrosine-phosphorylated tie-2 receptors (12) . Activation of the PI-3 kinase pathway by Ang-1 exposure triggers protein kinase B (AKT) phosphorylation, which, in turn, promotes survival and inhibits apoptosis of cultured ECs (13, 14) . Jones and Dumont (15) have also found that Dok-R, a novel-docking molecule involved in promoting EC migration, associates with activated tie-2 receptors and triggers the activation of p21-activated protein (PAK-1), which, in turn, partially mediates Ang-1-induced EC migration. In addition, our group has recently reported that two members of the mitogen-activated protein kinases (MAPKs), namely, the extracellular signal-regulated kinases (Erk1/2) and the p38 MAPKs, are activated by Ang-1 exposure in ECs and that the Erk1/2 pathway promotes EC survival, whereas the p38 MAPKs enhance EC apoptosis (16) . Despite recent progress in understanding tie-2 receptor signaling, little is known about the mechanisms linking these receptors to downstream effectors such as MAPK family proteins.
Reactive oxygen species (ROS) have long been considered toxic by-products of cellular metabolism. However, recent evidence suggests that ROS are produced transiently in response to receptor activation in a variety of cells and play important roles as second messengers downstream of RTKs (17) . Indeed, ROS contribute to VEGF-and PDGF-induced phosphorylation of the PI-3 kinase, AKT, Erk1/2, and p38 MAPKs in ECs (18) . While ROS are likely to originate from several intracellular sources, including the mitochondrial electron transport chain, nitric oxide synthase (NOS), xanthine oxidase, and lipoxygenases, recent studies implicate an NADPH oxidase enzyme complex in the generation of ROS in response to RTK activation in vascular cells (18 (20) . Observations that inhibition of Rac-1 activity or reduction in gp91 phox expression prevents VEGF-induced proliferation and migration in ECs suggest that NADPH oxidase plays an important functional role in promoting angiogenesis (21) . To our knowledge, no information is yet available concerning ROS production in response to Ang-1 treatment in ECs.
The main goals of this study were to determine whether 1) tie-2 receptor activation by Ang-1 triggers ROS generation; 2) the NADPH oxidase enzyme complex is the primary source of ROS production in response to tie-2 receptor activation; 3) ROS are involved in linking tie-2 receptors to downstream effectors such as MAPKs, PAK-1, and AKT; and 4) ROS generation is an important mediator of Ang-1/tie-2 receptor-induced EC migration.
MATERIALS AND METHODS

Materials
Antibodies selective to total and phospho-AKT, phospho-Raf-1, total and phospho-Erk1/2, total and phospho-p38, total and phospho SAPK/JNK, and total and phospho-PAK-1 were purchased from New England Biolabs (Beverly, MA). Polyclonal phospho-tie-2 antibody was obtained from Oncogene Research Products (Boston, MA). Ang-1 protein and its cross-linking antibody were supplied by R&D Systems (Cedarlane Laboratories Ltd., Hornby, ON). Superoxide dismutase (SOD), diphenyleneiodonium (DPI), rotenone, indomethacin, wortmannin, N G -nitro-L-arginine methyl ester (L-NAME), lucigenin, NADPH, and fibronectin were all obtained from Sigma (St. Louis, MO). AAA-AKT adenoviruses were a generous gift from Dr. K. Walsh (St. Elizabeth's Medical Center of Boston). Adenoviruses expressing GFP (Ad-GFP) were purchased from the Gene Transfer Vector Core of the University of Iowa (Iowa City, IA).
Cell cultures and transfections
Human umbilical vein endothelial cells (HUVECs) were obtained from GlycoTech Corporation (Rockville, MD) and cultured in standard growth medium consisting of MCDB131 basal medium supplemented with 20% fetal bovine serum (FBS), 2 mM L-glutamine (Invitrogen, Burlington, ON), endothelial cell growth supplement (Biomedical Technologies, Stoughton, MA), and heparin. Cells were obtained from a single donor and were used between passages 2 and 5. After reaching the first confluence in 100 mm dishes (within 1 wk), the cells were subcultured following trypsin (0.025%) and EDTA (0.01%) application and plated at a density of 2500 cells/cm 2 .
Lucigenin-derived chemiluminescence (LDCL)
After reaching ~80% confluence, the cells were washed twice with phosphate-buffered saline (PBS) and were incubated for 12-16 h with basal medium supplemented with heparin. Cells were then washed, resuspended in a glass tube containing phenol red-free basal medium, and incubated in a 37°C water bath for 10 min. Lucigenin (5μM) and NADPH (250 μM) were then added to the tube, which was then immediately placed inside the luminometer (Lumat LB 9501, Berthold Technologies, Pforzheim, Germany). LDCL was measured for a 10-min period. Cells were then stimulated with Ang-1 solvent (0.1% bovine serum albumin in PBS) or Ang-1 (50 ng/ml), and LDCL was monitored for 30 min. In a few experiments, the enzymatic origin of ROS produced in response to Ang-1 (100 ng/ml) was evaluated by adding L-NAME (a nitric oxide synthase inhibitor,100 μM), DPI (inhibitor of flavoenzymes, 100 μM), rotenone (inhibitor of complex I of the mitochondrial respiratory chain, 100 μM), indomethacin (inhibitor of cyclooxygenases, 100 μM), and wortmannin (WM, 100 nM) and LY294002 (10 μM) (inhibitors of the PI-3 kinase). To assess the specificity of the LDCL signal and the contribution of Rac-1 protein in Ang-1-induced ROS production, cells were infected with adenoviruses expressing Cu/Zn SOD (Ad-SOD), dominant-negative Rac-1 (Rac1N17) (22) , or GFP (Ad-GFP). Cells were infected overnight with each adenovirus (MOI of 100-200) in basal medium containing heparin. These conditions resulted in uniform expression of the transgenes in ∼95% of the cells, as assessed by green fluorescence protein (GFP) fluorescence. The viruses were then removed, and the cells were washed and allowed to recover for 1-2 days in complete medium. LDCL signals in response to Ang-1 (50 ng/ml) or solvent were then measured as described above.
To evaluate the contribution of NADPH oxidase to Ang-1-induced chemiluminescence signal, we inhibited NADPH oxidase activity by using a 9-amino acid peptide (gp91ds-tat), which recognizes the p47 phox binding site of gp91 phox (23) . This peptide was conjugated to the internalization sequence of HIV-tat to allow uptake of the peptide by cells. As a control, we also used a scrambled control peptide (scramb-tat) (23) . Cells were incubated with peptides (100 μM) in basal medium containing heparin for 3 h. Peptides were then washed, and Ang-1-induced LDCL was measured as described above.
DCFDA fluorescence
CM-H 2 DCFDA (5-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate, acetate ester) is a widely used intracellular ROS indicator. Following its passive diffusion inside cells, cleavage by intracellular esterases yields the nonfluorescent CM-DCFH, which is subsequently oxidized to fluorescent CM-DCF (dichlorofluorescein) by ROS. CM-DCF remains efficiently trapped in cells by means of its CM group, allowing for a stable signal to be measured over time. Subconfluent cells were cultured in 96-well plates in complete medium with supplements. Cells were serum starved for 3 h by using basal medium containing heparin and were then loaded with 5 μM CM-H 2 DCFDA for 30 min at 37°C in the dark. Cells were then washed and exposed either to Ang-1 solvent or Ang-1 (50 ng/ml). Fluorescence (Ex: 485 and Em: 530) was measured 15 min later using a microplate spectrofluorometer (SPECTRAmax GEMINI XS, Molecular Devices, Sunnyvale, CA).
The involvement of protein kinase B (AKT) and stress-activated protein kinase (SAPK/JNK) members of MAPKs in Ang-1-induced ROS production was evaluated by selectively inhibiting these pathways with dominant-negative forms of AKT and SAPK/JNK-1, respectively. To inhibit AKT activity, we used a HA-tagged inactive phosphorylation mutant AKT (AAA-AKT) that contains an alanine substitution at the active site (residue 179) in addition to two alanine substitutions at the regulatory phosphorylation sites (24) . HUVECs were infected with adenovirus (MOI of 100) expressing GFP or AAA-AKT for 12 h in complete medium in order to yield uniform expression of the transgenes. The viruses were then removed, and the cells were allowed to recover for 12 h in complete medium. Cells were then cultured in 96-well plates, loaded with CM-H 2 DCFDA, and exposed to Ang-1 solvent or Ang-1 (50 ng/ml). Fluorescence was measured as described above.
For SAPK/JNK inhibition, we used HUVECs that were transduced with a dominant-negative JNK/SAPK in which the phosphorylation site, Thr-Pro-Tyr, was mutated to Ala-Pro-Phe (JNK-APF) (25) . HUVEC-MSCV (as control) and HUVEC-MSCV-JNK-APF cells were constructed by retroviral transduction using MSCV-pac (empty vector) or MSCV-pac containing JNK-APF cDNA, respectively (26) . Expression of JNK-APF was confirmed by immunoblotting using an antibody for total JNK (Santa Cruz Biotechnology, Santa Cruz, CA). Infected cells were serum deprived for 1 h, loaded with CM-H 2 DCFDA, and then exposed to 50 ng/ml Ang-1 as described above.
Signaling assays
HUVECs were grown in 100 mm dishes to subconfluency in standard growth medium as described above. To assess the involvement of ROS in Ang-1-induced MAPK, PAK, and AKT phosphorylation, we used two approaches. First, we infected cells with adenoviruses expressing Cu/Zn SOD, catalase, or GFP, as described above. Cells were allowed to recover in complete medium for 1-2 days. Cells were then serum deprived in basal medium containing heparin overnight and were then exposed for 15 or 30 min to Ang-1 solvent or Ang-1 (100 ng/ml). In a few experiments, cells were exposed to VEGF (80 ng/ml) for 15 min. Second, we incubated cells with bovine erythrocyte Cu/Zn-SOD (500 U/ml) for 16 h in basal medium followed by washing and then exposure to Ang-1 solvent or Ang-1 as described above. The involvement of Rac-1 in Ang-1-induced MAPK, PAK, and AKT activation was evaluated by selectively inhibiting Rac-1 with a dominant-negative form delivered by adenoviruses (Ad-Rac1N17) as detailed above. The contribution of NADPH oxidase to Ang-1-evoked MAPK, PAK, and AKT activation was assessed by preincubating HUVECs with DPI (25 μM) for 1 h or by exposure for 3 h to gp91ds-tat and scramb-tat peptides (100 μM) peptides. Both were dissolved in basal medium containing heparin. DPI and peptides were then washed, and cells were exposed to Ang-1 solvent or Ang-1 (100 ng/ml) for 15 min. In all signaling experiments, adhered cells were collected in 300 μl of lysis buffer (pH 7.4) containing 50 mM HEPES, 150 mM NaCl, 100 mM sodium fluoride, 1 mM sodium orthovandate, 5 mM EDTA, 1 mg/ml PMSF, 10 μg/ml leupeptin, 10 μg/ml aprotinin, 10 μg/ml pepstatin A, 1 mM DTT, and 1% Triton X-100. Cell lysates were centrifuged at 14,000g for 5 min at 4°C. Supernatants were then assayed for protein phosphorylation and total protein expression using immunoblotting (see below).
Immunoblotting
Cell lysates (20-30 μg total protein per sample) were boiled for 5 min and then loaded onto Trisglycine SDS-polyacrylamide gels. Proteins were then electrophoretically transferred onto polyvinylidene difluoride membranes, blocked with 5% nonfat dry milk, and incubated with the primary antibodies. Activation of Erk1/2 was assessed with polyclonal antibodies specific to active (dually phosphorylated at Thre 183 and Tyr
185
) and total Erk1/2, whereas p38 and SAPK/JNK MAPK phosphorylation was monitored with polyclonal phospho-p38 (Thre 180 /Tyr 182 ), phospho-SAPK/JNK (Thre 183 /Tyr 185 ), and total p38 and total SAPK/JNK antibodies. Lysates of NIH/3T3, serum-induced PC12 cells, and UV-treated 293 cells were used as positive controls for p38, Erk1/2, and SAPK/JNK phosphorylation, respectively.
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Phosphorylation of Raf-1 and AKT was assessed with polyclonal antibodies selective to phosphorylated Raf-1(Ser
259
) and phosphorylated AKT (Ser 473 ), respectively. A phospho-specific tie-2 antibody recognizing residues 1089-1102 of human tie-2 receptors, which includes Tyr(P) 1101 residue, was used to evaluate tie-2 receptor phosphorylation (27) . For PAK-1 phosphorylation, we used three polyclonal antibodies (generously provided by Cell Signaling Technology, Beverly, MA) selective to the phosphorylated forms of PAK-1. These antibodies detect phosphorylation of Ser 199/204 , Ser 144 , and Thre 423 of PAK-1. Total PAK-1 protein was detected with a polyclonal antibody. Proteins were detected with horseradish peroxidaseconjugated anti-rabbit secondary antibodies and ECL reagents (Chemicon, Temecula, CA). The blots were scanned with an imaging densitometer (model GS700, 12-bit precision and 42-μm resolution, Bio-Rad, Hercules, CA), and optical densities of the protein bands were quantified with ImagePro Plus software (MediaCybernetics, San Diego, CA). Predetermined molecular weight standards were used as markers. Protein concentration was measured by the Bio-Rad protein assay with BSA as a standard (Bio-Rad Laboratories, Canada, Mississauga, ON).
Cell migration
EC migration was performed in 24-well transwell polycarbonate inserts with a pore size of 8.0 μm (Corning, Life Sciences, Acton, MA). The inserts were coated with 50 μg/ml fibronectin, followed by 0.1% gelatin for a minimum of 2 h each at 37°C. Ang-1 or solvent was diluted in basal medium (containing 1% FBS) and placed in the lower chamber. Subconfluent HUVECs were pretreated with scramb-tat or gp91-tat peptides, transfected with adenoviruses (see above), or preincubated 1 h with DPI. Cells were then washed, trypsinized, and resuspended at 10 5 cells/100 μl in basal medium and seeded in the upper compartment. The apparatus was then incubated at 37°C in a CO 2 incubator for 5 h to allow for cell migration. The inserts were then fixed with 10% buffered formalin for 20 min and stained with Giemsa solution for 30 min. The upper side of the insert was subsequently scraped with cotton swabs to remove nonmigrating cells. Migration was quantified using ImagePro Plus software by counting cells in 10 random fields (×200) per well.
Data analysis
Results are shown as means ± SE. For immunoblotting experiments, at least three independent measurements were performed within each group. Differences in the optical density (OD) between various groups and in the number of migrated cells were compared using two-way ANOVA. P < 0.05 was considered significant.
RESULTS
Production of ROS in response to Ang-1
Ang-1 (50 ng/ml) elicited a significant rise in LDCL signal, which rose progressively and reached a plateau 15 min later (Fig. 1A) . Mean values shown in Fig. 1B indicate that Ang-1 elicited about a twofold increase in the rate of LDCL signal over 15 min (P<0.05, Fig. 1B) . Similarly, measurements of ROS production using DCFDA fluorescence have revealed that Ang-1 exposure elicits a time-dependent increase in DCFA fluorescence, which was significantly greater than that observed with the solvent (P<0.05), confirming that Ang-1 triggers a rise in ROS levels (Fig. 1C, 1D ). Figure 2A demonstrates that infecting HUVECs with Ad-SOD abrogated the Ang-1-induced LDCL signal, whereas infection with Ad-GFP had no effect, indicating that O 2 -is the main ROS responsible for the Ang-1-induced LDCL signal. Similarly, the Ang-1-induced LDCL signal was significantly attenuated by expressing a dominant-negative form of Rac-1, suggesting that Rac-1 is involved in the production of ROS in response to Ang-1 exposure ( Fig. 2A) . We verified the molecular sources of O 2 -production by using various pharmacological inhibitors of ROSproducing pathways. Preincubation with L-NAME increased solvent-and Ang-1-induced LDCL signals by ~32 and 30%, respectively. By comparison, pretreatment with DPI substantially reduced Ang-1-induced LDCL signal to ~25.2 ± 2.1% of the initial value (Fig. 2B ). This inhibitory effect was relatively stronger than that observed with solvent-induced LDCL signal, which was attenuated to 40.1 ± 1.1% of the initial value. Pretreatment with indomethacin, wortmannin (WM), and LY294002 had no effect on Ang-1-and solvent-induced LDCL signals, but preincubation with rotenone elicited a relatively small (∼16%) reduction of these signals (Fig. 2B ). To assess whether O 2 -anions produced by HUVECs in response to Ang-1 originate from NADPH oxidase activity, we inhibited the activity of this enzyme with a selective peptide (gp91ds-tat) that blocks the association of the p47 phox with the gp91 phox subunits (28) . When cells were preincubated with this peptide, Ang-1 exposure did not elicit a significant rise in LDCL signal (Fig. 2C) . By comparison, pretreatment with the scrambled (scramb-tat) peptide had no effect on Ang-1-induced rise in LDCL signal (Fig. 2C) . To assess whether Ang-1-induced ROS production is mediated through SAPK/JNK or AKT activation, we inhibited these kinases using dominant-negative forms (see Materials and Methods) and measured DCFDA fluorescence in response to Ang-1 exposure. Transducing HUVECs with retroviruses expressing a dominantnegative JNK-1 (MSCV-JNK-APF) had no effect on Ang-1-induced DCFA fluorescence (results not shown). Similarly, Ang-1-induced rise in DCFDA fluorescence was not affected by the expression of inactive AKT phosphorylation mutant (AAA-AKT) (results not shown).
Nature and sources of ROS
Activation of Erk1/2
In HUVECs infected with Ad-GFP, incubation with Ang-1 (100 ng/ml) for 15 min elicited a significant rise in Erk1/2 phosphorylation (Fig. 3A) . Ang-1-induced Erk1/2 phosphorylation was potentiated in HUVECs infected with Ad-SOD and Ad-Rac1N17 (P<0.05 compared with Ad-GFP, Fig. 3B) . A smaller degree of potentiation of Ang-1-induced Erk1/2 phosphorylation was noticed in HUVECs infected with Ad-catalase (Fig. 3B) . Potentiation of Ang-1-induced Erk1/2 phosphorylation was also observed in HUVECs pretreated with DPI or bovine Cu/Zn SOD protein (Fig. 3C ) and in cells pretreated with gp91ds-tat peptide but not in cells pretreated with scramb-tat peptide. These results confirm the involvement of NADPH oxidase-derived ROS in regulating Erk1/2 phosphorylation in response to Ang-1 exposure. Incubation with DPI (results not shown) or bovine Cu/Zn SOD protein had no effects on Ang-1-induced tie-2 and Raf-1 phosphorylation (Fig. 3D) , suggesting that the mechanisms of potentiation of Erk1/2 phosphorylation in the presence of antioxidants and DPI reside downstream from Raf-1. It should be emphasized that overexpression of antioxidants (SOD and catalase) and Rac1N17 had an opposite effect on VEGF-induced Erk1/2 phosphorylation to that observed with Ang-1. Indeed, Fig. 3E and 3F show that VEGF-induced Erk1/2 phosphorylation was significantly attenuated in HUVECs infected with Ad-SOD, AD-catalase, and Ad-Rac1N17 as compared with Ad-GFP-infected cells (P<0.05). These results clearly illustrate fundamental differences in the role of ROS in regulating Erk1/2 phosphorylation between the Ang-1/tie-2 and VEGF/VEGF receptor pathways in HUVECs.
Activation of p38 MAPK
Infection of HUVECs with Ad-SOD, Ad-catalase, or Ad-Rac1N17 resulted in a more than twofold increase in basal (in the presence of solvent) p38 MAPK phosphorylation, compared with Ad-GFP-infected cells (Fig. 4A) . This response was also observed in cells pretreated with bovine Cu/Zn SOD protein (Fig. 4A) . By comparison, the intensity of p38 phosphorylation in response to Ang-1 exposure in cells infected with Ad-SOD, Ad-catalase, or Ad-Rac1N17 was similar to that of Ad-GFP-infected cells (Fig. 4A, 4B) . Thus, while Ang-1 was able to elicit a more than twofold increase in p38 phosphorylation in cells infected with Ad-GFP, Ang-1 failed to provoke further p38 phosphorylation in cells infected with Ad-SOD, Ad-catalase, orAdRac1N17 or in cells pretreated with bovine Cu/Zn SOD protein. This failure of Ang-1 to induce further phosphorylation of p38 proteins was also observed in cells pretreated with gp91ds-stat peptide, as compared with those treated with scramb-tat (Fig. 4C, 4D) . Figure 4E shows, as in the case of Ang-1, that VEGF exposure did not elicit further p38 phosphorylation in the presence of antioxidants as compared with the baseline level.
Activation of SAPK/JNK
We first assessed whether Ang-1 activates SAPK/JNK members of MAPK by exposing serum starved HUVECs to Ang-1 (100 ng/ml) for a period of 5, 15, 30, and 60 min. Ang-1 elicited a time-dependent and significant rise in the phosphorylation of the 54-kDa SAPK/JNK protein, which peaked within 15 min and declined thereafter (Fig. 5A , 5B). Infection of cells with Ad-SOD, Ad-catalase, or Ad-Rac1N17 had no effect on basal (in the presence of solvent) and Ang-1-indued SAPK/JNK phosphorylation (results not shown). Similarly, preincubation with gp91ds-tat peptide did not change the level of Ang-1-induced SAPK/JNK phosphorylation as compared with that observed with the scram-tat peptide (Fig. 5C ).
Activation of AKT
Ang-1 triggered a significant increase in AKT phosphorylation (Fig. 6) . Overexpression of SOD, catalase, and Rac1N17 and pretreatment with bovine Cu/Zn SOD failed to alter Ang-1-induced AKT phosphorylation (Fig. 6A, 6B) . Similarly, preincubation with gp91ds-tat peptide did not change the level of Ang-1-induced AKT phosphorylation as compared with that observed with the scram-tat peptide (Fig. 6C, 6D) .
Activation of PAK-1
We first assessed whether Ang-1 activates PAK-1 by exposing serum-starved HUVECs to Ang-1 (100 ng/ml) for a period of 5, 30, and 120 min. Ang-1 elicited a time-dependent increase (more than fourfold) in PAK-1 phosphorylation at Ser 199/204 after 30 min, with a decline thereafter (Fig.  7A) . Another residue of PAK-1, which has also been reported to be a target of phosphorylation, is Ser 144 (29, 30) . We found no significant increase in phosphorylation of this residue in response
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to Ang-1 exposure (Fig. 7A) . By comparison, we detected a more than fourfold increase in PAK-1 phosphorylation at Thre 423 (Fig. 7A, 7B) . Phosphorylation of PAK-1 at this residue is mediated by phosphorylated 3-phosphoinositide-dependent kinase 1 (PDK-1) and has been reported to increase PAK-1 activity (31). Ang-1 (100 ng/ml) exposure for 30 min induced a more than fiveand fourfold increase in phosphorylation of Ser 199/204 and Thre 423 of PAK-1 in cells infected with Ad-GFP, respectively (Fig. 7C) . The degree of Ang-1-induced PAK-1 phosphorylation at these residues was significantly smaller in cells infected with Ad-Rac1N17, Ad-SOD, and Ad-catalase compared with cells infected with Ad-GFP (P<0.05, Fig. 7C) . Similarly, the degree of Ang-1-induced PAK-1 phosphorylation at Ser 199/204 and Thre 423 was significantly lower in cells pretreated with gp91ds-tat peptide compared with those pretreated with scramb-tat peptide (results not shown).
EC migration
Ang-1 provoked a dose-dependent increase in EC migration that peaked at 100 ng/ml (Fig. 8A) . Overexpression of SOD, catalase, and Rac1N17 significantly (P<0.05) attenuated Ang-1-induced cell migration as compared with Ad-GFP-infected cells (Fig. 8B) . Similarly, pretreatment with DPI or gp91ds-stat peptide also reduced Ang-1-induced cell migration, whereas pretreatment with scramb-tat peptide had no effect on this response (Fig. 8C, 8D ).
DISCUSSION
The main findings of this study are that in HUVECs 1) Ang-1 exposure induced rapid rises in ROS levels, particularly of O 2 -anions; 2) The main source of O 2 -production triggered by Ang-1 is a Rac-1-dependent NADPH oxidase; 3) ROS act as messenger intermediates in tie-2 receptor signaling and are involved in the regulation of Erk1/2 and p38 MAPK phosphorylation but not AKT activation; 4) Ang-1 induced a significant and a transient increase in SAPK/JNK phosphorylation, which was not inhibited by antioxidants; 5) Ang-1 evoked significant PAK-1 phosphorylation at Ser 199/204 and Thre 423 and that phosphorylation of PAK-1 at these residues was significantly attenuated by antioxidants and NAPDH oxidase inhibition; and 6) Ang-1-induced ROS promotes cell migration.
Using two independent methods of ROS detection, we found that Ang-1 triggers the formation of ROS in HUVECs. The observations that ROS levels were strongly attenuated by overexpression of SOD and by preincubation with exogenous SOD suggest that O 2 -anions are the main ROS species produced in response to Ang-1 exposure in HUVECs. The importance of NADPH oxidase-derived ROS in mediating various signaling events in nonphagocytes has recently been reviewed (32) . Following receptor stimulation by ligands such as PDGF and VEGF, the vascular NADPH oxidase complex is activated through several mechanisms, including p47 phox phosphorylation and activation of Rac-1, resulting in the association of these two proteins with membrane-bound p22 phox and gp91 phox subunits (18) . The assembled NADPH oxidase complex will then produce O 2 -anions that target diverse signaling molecules. As a result of this study, we propose that Ang-1 exposure in HUVECs triggers the activation of NAPDH oxidase, resulting in enhanced O 2 -production. This proposal is supported by the observations that DPI and gp91ds-tat peptide strongly attenuated Ang-1-induced ROS generation and that selective inhibition of Rac-1 activation strongly reduced ROS generation by Ang-1. We should emphasize, however, that other ROS sources, including mitochondrial enzymes, might also contribute to ROS production
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by Ang-1, since rotenone pretreatment attenuated Ang-1-induced ROS generation. This reduction, however, was relatively smaller than that elicited by DPI and gp91ds-tat peptide, suggesting that the contribution of mitochondrial oxidoreductases to Ang-1-induced ROS generation is minor compared with that of the NADPH oxidase enzyme complex.
Many mechanisms exist that link receptor activation to NADPH oxidase in nonphagocytes. These include protein kinase C (PKC), the PI-3 kinase, and SAPK/JNK members of MAPKs, which augment NADPH oxidase activity by activating Rac-1 and/or by phosphorylating the p47 phox subunit (33) (34) (35) . Our data suggest that the Rac-1 protein is necessary for Ang-1-induced NADPH oxidase in HUVECs because selective inhibition of the activity of this protein resulted in strong attenuation of Ang-1-induced ROS production (Fig. 2) . We should also emphasize that the PI-3 kinase, AKT, and SAPK/JNK pathways are not involved in NADPH oxidase activation by Ang-1 since selective inhibitors of these pathways did not alter ROS levels. In this regard, the Ang-1/tie-2 receptor system is clearly different from the VEGF/VEGF receptor pathway, which depends on Rac-1 activation by the PI-3 kinase pathway for ROS generation in ECs (35) . Although we did not identify upstream modulators of Rac-1 activity in Ang-1-treated cells, we propose that one likely candidate is the p21
Ras , which strongly activates the Rac-1 protein in response to PDGF receptor activation in nonphagocytes (17) . Other possible modulators of Rac-1 activity are SH2-containing adaptor proteins, which are recruited to phosphorylated tie-2 receptors and act as molecular scaffolds to promote the recruitment of Rac-1 to the other subunits of NADPH oxidases (36) .
We have previously reported that Ang-1 induces significant phosphorylation of the Erk1/2 and the p38 members of the MAPKs (16) . In this study, we report that Ang-1 is also capable of inducing significant SAPK/JNK phosphorylation, indicating that the three members of MAPKs are activated by Ang-1 exposure in HUVECs. MAPKs are known to be targets for ROS action. However, the nature of ROS effects on these kinases, particularly on Erk1/2 activation, is highly dependent on many factors, including the type of receptors involved and the molecular sources, and the nature of ROS being produced. In many studies, ROS activate Erk1/2 phosphorylation, as in the case of VEGF receptors in porcine ECs (35) . Our results, in terms of VEGF exposure, are in agreement with these findings (Fig. 3) . There are, however, few studies that documented an inhibitory effect of ROS on Erk1/2 phosphorylation (37) (38) (39) . In this study, we demonstrate for the first time that Ang-1-induced ROS exert an inhibitory effect on Erk1/2 phosphorylation, since antioxidants and NADPH oxidase inhibitors strongly potentiated Ang-1-induced Erk1/2 phosphorylation. It appears that tie-2 receptors or Raf-1 are not targets of ROS since Ang-1-induced phosphorylation of these two proteins was not altered by antioxidants. These results suggest that Ang-1-triggered ROS may target MEK or Erk1/2 themselves and/or may influence the activity of SHP-2, a protein tyrosine phosphatase that promotes Erk1/2 phosphorylation (40) . The biological significance of Ang-1-induced ROS effects on Erk1/2 activation was not assessed in this study. However, on the basis of our recent finding of an antiapoptotic role of the Erk1/2 pathway in ECs (16), one might expect that Ang-1-induced ROS may attenuate the antiapoptotic effect of Ang-1 by reducing Erk1/2 activation. Although possible, we speculate that this attenuation might be relatively small, since Ang-1 was still capable of eliciting robust Erk1/2 phosphorylation even in the presence of intact NADPH oxidase activity (Fig. 3) . Our results also indicate that the Erk1/2 pathway does not play a direct role in Ang-1-induced EC migration since antioxidants abrogated this effect of Ang-1 despite the rise in Erk1/2 phosphorylation. Fujikawa In addition to the Erk1/2 pathway, the p38 members of the MAPK pathways are also redox sensitive. Previous studies have indicated that ROS may either selectively target the Erk1/2 and the p38 pathways or both pathways may be simultaneously activated by ROS (42, 43) . We report here that antioxidants and NADPH oxidase inhibitors significantly elevate basal p38 phosphorylation, suggesting that basal ROS production derived from constitutive NADPH oxidase activity selectively inhibits p38 phosphorylation. We also found that Ang-1 and VEGF do not elicita further increase in p38 phosphorylation in the presence of antioxidants and NADPH oxidase inhibitors. We speculate that reduction of ROS by antioxidants at baseline conditions saturates the level of phosphorylated p38, thereby preventing further phosphorylation by either agonist.
We describe for the first time that Ang-1 exposure elicited a time-dependent rise in PAK-1 phosphorylation at Ser 199/204 and Thre 423 (Fig. 7) . PAK-1 is a serine/threonine protein kinase that serves as an important regulator of cytoskeletal dynamics and cell motility, transcription through MAPK cascades, death and survival signaling, and cell-cycle progression (44) . PAK-1 activation is regulated by the binding of GTPases (Rac1, Rac2, Rac3, and Cdc42) to the amino terminal regulatory domain and the subsequent autophosphorylation of multiple sites, including Ser 144 , Ser 199 , and Ser 204 , resulting in induction of kinase activity (29, 30, 44) . In addition, a number of GTPase-independent PAK-1 activation mechanisms have been identified, including PDK-1, which phosphorylates PAK-1 at Thre 423 and enhances PAK-1 activity (31) . The only published report of PAK-1 activation by the Ang-1/tie-2 receptor pathway is that of Master et al. (45) , who described that phosphorylation of tie-2 receptors by Ang-1 exposure in ECs elicits the recruitment of Dok-R and Nck proteins to these receptors and the subsequent activation of PAK. Our results of increased PAK-1 phosphorylation in response to Ang-1 are in accordance with the results of Master et al. and are consistent with the notion that recruitment of PAK-1 to activated tie-2 receptors by Dok-R and Nck helps localize PAK-1 in proximity to PDK-1 and in an environment that promotes phosphorylation at the critical Thre 423 residue. This notion is supported by the observations that growth factor receptors stimulate the formation and metabolism of sphingolipids and that PAK-1 is directly stimulated by sphingosine and sphingosine-derived lipids (46) . Our results do not exclude the possibility other kinases such as the PI-3 kinase, AKT, and Src may directly phosphorylate and activate PAK-1 in a GTPaseindependent manner in vivo (44) .
Previous reports have shown that Ang-1 promotes chemotaxis of ECs (8, 47) . These observations have been confirmed in our current study (Fig. 8) . We also report for the first time that Ang-1-induced EC migration requires the activity of NADPH oxidase, since selective inhibitors of this enzyme significantly attenuate this response (Fig. 8) . These results are in agreement with recent studies confirming the importance of NADPH oxidase in actin organization (48) and in serumand VEGF-induced EC migration (49, 50) . Although we did not directly assess the mechanisms through which ROS promote EC migration, we speculate that PAK-1 activation is one of these mechanisms. This is based on the following three observations. First, PAK-1 is activated in response to Ang-1 exposure in ECs (45) . Our current results of significant rise in PAK-1 phosphorylation at Ser 199/204 and Thre 423 in response to Ang-1 support this notion (Fig. 7) . Second, PAK-1 activation by growth factors is mediated in part by ROS. Indeed, we found that (Fig. 7) . Weber et al. (51) reported a similar attenuation of PDGF-induced PAK-1 phosphorylation by ROS inhibitors in vascular smooth muscles. These authors have also proposed that ROS sensitivity of PAK-1 activation is mediated through PDK-1 since tyrosine phosphorylation of the latter is also ROS dependent. Third, Ang-1/tie-2-mediated PAK activation is required for initiation of EC migration (45) . The importance of PAK-1 in growth factor-induced chemotaxis has also been confirmed in other vascular cells (51) .
We should emphasize that another important modulator of cell motility is the PI-3 kinase pathway, which could enhance cell migration through several mechanisms, including increased PDK-1 phosphorylation, direct phosphorylation, and activation of PAK proteins and/or activation of small GTPases such as RhoA and Rac-1 (52). The importance of the PI-3 kinase pathway in mediating Ang-1-induced Rac-1 activation and EC migration has been confirmed in several studies (12, 41, 52) . Our study does not rule out the possibility that Ang-1-induced ROS may promote EC migration by modulating the activity of the PI-3 kinase. Evidence of the importance of ROS in promoting PI-3 kinase activation in response to PDGF and EGF has been documented in cells overexpressing NAPDH oxidase (53). Clearly, further studies are needed to elucidate the exact mechanisms through which ROS modulate biological effects of Ang-1 in ECs.
In summary, our study indicates that exposure of ECs to Ang-1 triggers the generation of ROS, particularly from the NADPH oxidase enzyme complex. These ROS promote EC migration and PAK-1 phosphorylation while exerting a negative influence on Erk1/2 phosphorylation. Our results also suggest that ROS derived from constitutive NAPDH oxidase activity inhibit baseline p38 MAPK phosphorylation. These results are consistent with the notion that ROS are important signaling intermediates in the Ang-1/tie-2 receptor pathway.
ACKNOWLEDGMENTS
This study is supported by grants from the Heart and Stroke Foundation of Quebec. S. Hussain is a Chercheur Nationaux of the F.R.S.Q. R. R. Harfouche is a holder of Studentship of F.R.S.Q. We are grateful to Cell Signaling Technology for providing many phospho-specific and total PAK-1 antibodies free of charge. # P < 0.05 compared with that triggered by Ang-1 in cells infected with Ad-GFP (n=6 in each group). C) Ang-1 induced cell migration in the absence and presence of DPI. Results are shown as the percentage of Ang-1 solvent. *P < 0.05 compared with Ang-1 solvent.
REFERENCES
# P < 0.05 compared with that triggered by Ang-1 in the absence of DPI (n=6 in each group). D) Ang-1 induced migration in cells preincubated with scramb-tat or gp91ds-tat peptides. Results are shown as the percentage of that measured in the presence of Ang-1 solvent. *P < 0.05 compared with Ang-1 solvent.
# P < 0.05 compared with that triggered by Ang-1 in cells preincubated with scramb-tat peptide (n=6 in each group).
